Roche's Dx Sales Increase 3 Percent in Q1 | GenomeWeb

NEW YORK (GenomeWeb News) – Roche reported today that first-quarter revenues for its diagnostics division, which includes its molecular diagnostics and applied science businesses, rose 3 percent to CHF2.36 billion ($2.06 billion) year over year.

The Swiss drugs and diagnostics giant said that its molecular diagnostics business brought in revenues of CHF294 million for the quarter with growth driven by automated real-time PCR platforms and blood-screening products.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.

The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.

The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.

Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."